NeuroPsy InfoHub adună studii și articole verificate editorial despre sănătate mintală și afecțiuni neurologice — pentru pacienți, familii și specialiști.
This study proposes a diagnostic framework for childhood ADHD by extracting amplitude modulation features from EEG signals decomposed via wavelet analysis, achieving 99.46% accuracy with a KNN classifier. The approach integrates conventional and novel AM features, with discriminative information concentrated in gamma/beta bands and frontal brain regions, outperforming previous methods.
This meta-ethnographic synthesis of 25 qualitative studies (2000-2023) examines how ADHD affects university students' academic performance, social interactions, and overall well-being, with prevalence estimated at approximately 16%. Findings reveal common struggles with organization, time management, and focus, alongside challenges with university transitions and insufficient generic accommodations, while highlighting that tailored support and peer programs significantly enhance academic success.
A case report describes a patient with ADHD and treatment-resistant depression who developed serotonin syndrome postoperatively due to concurrent use of venlafaxine, opioids, stimulants, and cannabis. The condition was diagnosed using Hunter criteria and successfully reversed through discontinuation of serotonergic medications and supportive care.
This randomized controlled trial compared traditional face-to-face and online asynchronous behavioral parent training for young children with ADHD (n=196, mean age 50 months) against a wait-list control, with both formats showing equivalent effectiveness on parent-rated and masked behavioral assessments. Online delivery proved as feasible and acceptable as in-person sessions, suggesting it may reduce access barriers while maintaining therapeutic benefit.
This review examines MRI findings showing thalamic structural and functional abnormalities in children with ADHD, including reduced volume in specific nuclei and impaired white matter pathways. Evidence indicates that medications like methylphenidate and atomoxetine can promote normalization of thalamic structure and network connectivity, with thalamic imaging metrics showing promise as biomarkers for genetic risk assessment, clinical subtype classification, and treatment prediction.